| MeSH term | MeSH ID | Detail |
|---|---|---|
| Reproductive Tract Infections | D060737 | 1 associated lipids |
| Chlamydial Pneumonia | D061387 | 2 associated lipids |
| Pneumonia, Lipid | D011017 | 2 associated lipids |
| Protozoan Infections | D011528 | 6 associated lipids |
| Tick Bites | D064927 | 1 associated lipids |
| Granulomatous Mastitis | D058890 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Graybill JR and Bocanegra R | Treatment alternatives for Mycobacterium kansasii. | 2001 | J. Antimicrob. Chemother. | pmid:11266413 |
| Ferwerda A et al. | Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. | 2001 | J. Antimicrob. Chemother. | pmid:11266417 |
| Butler T et al. | In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. | 2001 | J. Antimicrob. Chemother. | pmid:11266420 |
| St Clair EW et al. | The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. | 2001 | Arthritis Rheum. | pmid:11357896 |
| Kaplan EL et al. | Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). | 2001 | Clin. Infect. Dis. | pmid:11360224 |
| Nilius AM et al. | Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. | 2001 | Antimicrob. Agents Chemother. | pmid:11408246 |
| Vallejo C et al. | Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. | 2001 | Haematologica | pmid:11146586 |
| Schlegel L et al. | In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999. | 2001 | Clin. Microbiol. Infect. | pmid:11531981 |
| Kurdowska A et al. | The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. | 2001 | J. Antimicrob. Chemother. | pmid:11389120 |
| Thompson C et al. | A family cluster of Chlamydia trachomatis infection. | 2001 | BMJ | pmid:11408308 |
| Jacobson GF et al. | A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. | 2001 | Am. J. Obstet. Gynecol. | pmid:11408852 |
| Matsunaga T | [Pharmacological and pharmacokinetic properties of azithromycin (Zithromac), a novel 15-membered ring macrolide antibacterial agent]. | 2001 | Nippon Yakurigaku Zasshi | pmid:11411344 |
| Kain KC et al. | Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. | 2001 | Clin. Infect. Dis. | pmid:11418883 |
| Tabbara KF | Trachoma: a review. | 2001 | J Chemother | pmid:11434524 |
| Lisby G et al. | Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin. | 2001 | Clin. Infect. Dis. | pmid:11438918 |
| Ishimatsu Y et al. | [Effect of macrolide antibiotics on apoptosis induction]. | 2001 | Jpn J Antibiot | pmid:11439895 |
| O'Farrell N | Donovanosis: an update. | 2001 | Int J STD AIDS | pmid:11394976 |
| Schmutz JL et al. | [Skin eruptions due to azithromycin (Azadose-Zithromax) and infectious mononucleosis]. | 2001 | Ann Dermatol Venereol | pmid:11395665 |
| Amsden G et al. | Lack of an effect of azithromycin on the disposition of zidovudine and dideoxyinosine in HIV-infected patients. | 2001 | J Clin Pharmacol | pmid:11210404 |
| Tyteca D et al. | Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts. | 2001 | Eur. J. Cell Biol. | pmid:11499789 |
| Chokephaibulkit K et al. | Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. | 2001 | Southeast Asian J. Trop. Med. Public Health | pmid:12041552 |
| Solera J et al. | Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. | 2001 | Clin. Infect. Dis. | pmid:11170962 |
| Gerber MA and Tanz RR | New approaches to the treatment of group A streptococcal pharyngitis. | 2001 | Curr. Opin. Pediatr. | pmid:11176244 |
| Conrad DA | Treatment of cat-scratch disease. | 2001 | Curr. Opin. Pediatr. | pmid:11176245 |
| Mamikoglu B and Mamikoglu O | Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report. | 2001 | Ann. Otol. Rhinol. Laryngol. | pmid:11201801 |
| Sahm DF et al. | Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. | 2001 | Antimicrob. Agents Chemother. | pmid:11257013 |
| Lietman T and Fry A | Can we eliminate trachoma? | 2001 | Br J Ophthalmol | pmid:11264123 |
| Fuchs PC et al. | Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. | 2001 | J. Clin. Microbiol. | pmid:11136745 |
| Citterio F et al. | Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe. | 2001 | Transplant. Proc. | pmid:11377476 |
| Solomon AW et al. | Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. | 2001 | Bull. World Health Organ. | pmid:11217675 |
| Mizen L | The activity of antibiotics against Legionella pneumophila: in vitro and in vivo studies. | 2001 | J. Antimicrob. Chemother. | pmid:11222573 |
| Amsden GW and Gray CL | Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. | 2001 | J. Antimicrob. Chemother. | pmid:11152432 |
| Giacometti A et al. | Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. | 2001 | J. Antimicrob. Chemother. | pmid:11152438 |
| Gieffers J et al. | Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. | 2001 | Circulation | pmid:11157684 |
| Weiss LM et al. | The treatment of babesiosis. | 2001 | N. Engl. J. Med. | pmid:11236789 |
| Nagai K et al. | Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. | 2001 | Antimicrob. Agents Chemother. | pmid:11600391 |
| De Diego JI et al. | Comparison of amoxicillin and azithromycin in the prevention of recurrent acute otitis media. | 2001 | Int. J. Pediatr. Otorhinolaryngol. | pmid:11249979 |
| Ioannidis JP et al. | Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. | 2001 | J. Antimicrob. Chemother. | pmid:11679557 |
| Contopoulos-Ioannidis DG et al. | Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. | 2001 | J. Antimicrob. Chemother. | pmid:11679558 |
| Laurent J et al. | A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. | 2001 | Aliment. Pharmacol. Ther. | pmid:11683693 |
| Woolard S and Kenkel D | Heading off antibiotic resistance. | 2001 | Adv Nurse Pract | pmid:12420432 |
| Chahine C et al. | Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. | 2001 | Am J Health Syst Pharm | pmid:11596697 |
| Weigl LB et al. | [Confluent and reticulate papillomatosis. Successful therapy with azithromycin]. | 2001 | Hautarzt | pmid:11715390 |
| Gray RH et al. | Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. | 2001 | Am. J. Obstet. Gynecol. | pmid:11717659 |
| Intrauterine devices: antibiotic prophylaxis not necessary during insertion. | 2001 | Prescrire Int | pmid:11718174 | |
| Golledge CL and Riley TV | The efficacy of an antibiotic protocol for community-acquired pneumonia. | 2001 | Med. J. Aust. | pmid:11700844 |
| Toro C et al. | [Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]. | 2001 | Rev Esp Quimioter | pmid:11704771 |
| Tajima T et al. | [Discussions on PRSP and BLNAR]. | 2001 | Jpn J Antibiot | pmid:12638161 |
| Samarendra P et al. | QT prolongation associated with azithromycin/amiodarone combination. | 2001 | Pacing Clin Electrophysiol | pmid:11707055 |
| Hand WL and Hand DL | Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. | 2001 | Int. J. Antimicrob. Agents | pmid:11711255 |
| Treadway G and Reisman A | Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases. | 2001 | Int. J. Antimicrob. Agents | pmid:11711256 |
| Page RL et al. | Possible interaction between intravenous azithromycin and oral cyclosporine. | 2001 | Pharmacotherapy | pmid:11714218 |
| Amsden GW | Advanced-generation macrolides: tissue-directed antibiotics. | 2001 | Int. J. Antimicrob. Agents | pmid:11574189 |
| Malizia T et al. | Interaction between piroxicam and azithromycin during distribution to human periodontal tissues. | 2001 | J. Periodontol. | pmid:11577945 |
| Salopek-Rabatić J | Chlamydial conjunctivitis in contact lens wearers: successful treatment with single dose azithromycin. | 2001 | CLAO J | pmid:11725983 |
| Butler T | Effect of increased inoculum of Salmonella typhi on MIC of azithromycin and resultant growth characteristics. | 2001 | J. Antimicrob. Chemother. | pmid:11733476 |
| Dillon JA et al. | Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. | 2001 | Sex Transm Dis | pmid:11518869 |
| Damianov L et al. | [Treatment of genital chlamydia infections with Sumamed]. | 2001 | Akush Ginekol (Sofiia) | pmid:11519320 |
| Doern GV | Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. | 2001 | Clin. Infect. Dis. | pmid:11524718 |
| Noedl H et al. | Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. | 2001 | Acta Trop. | pmid:11495642 |
| Fraser-Hurt N et al. | Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. | 2001 | Bull. World Health Organ. | pmid:11477966 |
| Skerk V et al. | Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. | 2001 | Drugs Exp Clin Res | pmid:11822223 |
| [Antibiotics in respiratory tract infections. Enormous differences in compliance]. | 2001 | MMW Fortschr Med | pmid:11824169 | |
| [Chronic bronchitis. When to use antibiotics?]. | 2001 | MMW Fortschr Med | pmid:11824170 | |
| Samra Z et al. | In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. | 2001 | Diagn. Microbiol. Infect. Dis. | pmid:11337185 |
| Calvo A et al. | [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae]. | 2001 | Rev Esp Quimioter | pmid:11856980 |
| Martinez SM et al. | Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness. | 2001 | Infect Control Hosp Epidemiol | pmid:11876458 |
| Mendes CM et al. | In vitro susceptibility of gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents. | 2001 | Braz J Infect Dis | pmid:11779453 |
| Castor D et al. | Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago. | 2001 | Cell. Mol. Biol. (Noisy-le-grand) | pmid:11785665 |
| van der Griend B et al. | An uncommon cause of a destructive vulval lesion. | 2001 | Aust N Z J Obstet Gynaecol | pmid:11787928 |
| Bain DL et al. | Chlamydial genovar distribution after community wide antibiotic treatment. | 2001 | J. Infect. Dis. | pmid:11740734 |
| Najib NM et al. | Bioequivalence assessment of Azomycin (Julphar, UAE) as compared to Zithromax (Pfizer, USA)--two brands of azithromycin--in healthy human volunteers. | 2001 | Biopharm Drug Dispos | pmid:11745903 |
| Skerk V et al. | Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. | 2001 | J Chemother | pmid:11806631 |
| Stiefelhagen P | [Treatment refractory fever... und then also the kidneys fail]. | 2001 | MMW Fortschr Med | pmid:11808449 |
| Andersen SE et al. | [Failed azithromycin treatment of Chlamydia trachomatis infection]. | 2001 | Ugeskr. Laeg. | pmid:11810790 |
| Zarantonelli L et al. | Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. | 2001 | J. Antimicrob. Chemother. | pmid:11328778 |
| Safak MA et al. | A comparative study of azithromycin and pseudoephedrine hydrochloride for otitis media with effusion in children. | 2001 | Acta Otolaryngol. | pmid:11813896 |
| Kastner U and Guggenbichler JP | Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. | 2001 | Infection | pmid:11688901 |
| Treadway G | Azithromycin: a new 15-membered macrolide. | 2001 | Jpn J Antibiot | pmid:11296412 |
| Hafner R et al. | Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. | 2001 | Antimicrob. Agents Chemother. | pmid:11302832 |
| Stein GE and Schooley S | Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and resistant strains of Streptococcus pneumoniae. | 2001 | Diagn. Microbiol. Infect. Dis. | pmid:11337186 |
| Griffith DE et al. | Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. | 2001 | Clin. Infect. Dis. | pmid:11340525 |
| Dinos GP et al. | Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. | 2001 | Mol. Pharmacol. | pmid:11353804 |
| Nagata T et al. | [Two cases successfully treated with long-term administration of low-dosage azithromycin]. | 2001 | Jpn J Antibiot | pmid:12575407 |
| Dreses-Werringloer U et al. | Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. | 2001 | Antimicrob. Agents Chemother. | pmid:11600348 |
| Littler WA | Clindamycin suspension and endocarditis prophylaxis. | 2001 | Br Dent J | pmid:11352383 |
| Ikegaya S et al. | [Effect of azithromycin on cytokine production by THP-1 cells]. | 2001 | Jpn J Antibiot | pmid:12575425 |
| Tateda K et al. | Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. | 2001 | Antimicrob. Agents Chemother. | pmid:11353657 |
| Kato T et al. | [Effect of azithromycin on cytokine production in human bronchial epithelial cell line, BEAS-2B]. | 2001 | Jpn J Antibiot | pmid:12575426 |
| Pechère JC | Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensing. | 2001 | Jpn J Antibiot | pmid:12575427 |
| Holm SO et al. | Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. | 2001 | Bull. World Health Organ. | pmid:11285662 |
| Tateda K et al. | [MIC, sub-MIC of macrolide resistant bacteria--special reference to their quorum-sensing system]. | 2001 | Jpn J Antibiot | pmid:12575433 |
| Frick KD et al. | Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. | 2001 | Bull. World Health Organ. | pmid:11285663 |
| Bailey R and Lietman T | The SAFE strategy for the elimination of trachoma by 2020: will it work? | 2001 | Bull. World Health Organ. | pmid:11285668 |
| Sorvillo F et al. | Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. | 2001 | Am J Infect Control | pmid:11287873 |
| Edelstein PH et al. | In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. | 2001 | Antimicrob. Agents Chemother. | pmid:11451675 |
| Rubinstein E | Comparative safety of the different macrolides. | 2001 | Int. J. Antimicrob. Agents | pmid:11574199 |
| Skerk V et al. | Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. | 2001 | J Chemother | pmid:11330365 |
| RodrÃguez Núñez A et al. | [Chemoprophylaxis of meningococcal disease with azithromycin and ciprofloxacin]. | 2001 | An. Esp. Pediatr. | pmid:11333489 |
| Grand A et al. | [Subacute infectious endocarditis due to the agent of cat scratch fever: Bartonella henselae]. | 2001 | Arch Mal Coeur Vaiss | pmid:11265556 |